Market Overview: The global Whole Genome and Exome Sequencing market size was estimated at USD 296.0 million in 2023 and is projected to reach USD 630.21 million by 2030, exhibiting a CAGR of 11.40% during the forecast period. Definition and Scope: Whole Genome Sequencing sequences the complete DNA of an organism. In the case of a human this corresponds to about three billion base pairs of DNA. Whole genome sequencing entails sequencing all coding (exons) and noncoding (intron) nuclear DNA as well as mitochondrial DNA. This allows researchers to generate large quantities of data, which can then be analyzed.The exome makes up only 1.5% of the whole human genome, however ALL protein coding genes are found in the exome. Since most genetic disorders are correlated with mutations in protein coding genes, most physicians and scientists who use sequencing technologies for diagnostic purposes start with an analysis of the exome. This report offers a comprehensive analysis of the global Whole Genome and Exome Sequencing market, examining all key dimensions. It provides both a macro-level overview and micro-level market details, including market size, trends, competitive landscape, niche segments, growth drivers, and key challenges. Report Framework and Key Highlights: Market Dynamics: Identification of major market drivers, restraints, opportunities, and challenges. Trend Analysis: Examination of ongoing and emerging trends impacting the market. Competitive Landscape: Detailed profiles and market positioning of major players, including market share, operational status, product offerings, and strategic developments. Strategic Analysis Tools: SWOT Analysis, Porter’s Five Forces Analysis, PEST Analysis, Value Chain Analysis Market Segmentation: By type, application, region, and end-user industry. Forecasting and Growth Projections: In-depth revenue forecasts and CAGR analysis through 2033. This report equips readers with critical insights to navigate competitive dynamics and develop effective strategies. Whether assessing a new market entry or refining existing strategies, the report serves as a valuable tool for: Industry players Investors Researchers Consultants Business strategists And all stakeholders with an interest or investment in the Whole Genome and Exome Sequencing market. Global Whole Genome and Exome Sequencing Market: Segmentation Analysis and Strategic Insights This section of the report provides an in-depth segmentation analysis of the global Whole Genome and Exome Sequencing market. The market is segmented based on region (country), manufacturer, product type, and application. Segmentation enables a more precise understanding of market dynamics and facilitates targeted strategies across product development, marketing, and sales. By breaking the market into meaningful subsets, stakeholders can better tailor their offerings to the specific needs of each segment—enhancing competitiveness and improving return on investment. Global Whole Genome and Exome Sequencing Market: Market Segmentation Analysis The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments. Key Companies Profiled Eurofins Scientific SE Agilent Technologies Inc Beijing Genomics Institute (BGI) Hoffmann-La Roche Ltd Bio-Rad Laboratories Inc GENEWIZ Inc Illumina Inc Laboratory Corporation of America Holdings Novogene Corporation Oxford Nanopore Technologies Inc Pacific Biosciences of California Inc QIAGEN N.V Thermo Fisher Scientific Inc Cytiva Market Segmentation by Type Kits Instruments Market Segmentation by Application Hospitals and Clinics Pharmaceutical and Biotechnology Companies Diagnostic Labs Research Centres, Academia and Government Institutes Others Geographic Segmentation North America: United States, Canada, Mexico Europe: Germany, France, Italy, U.K., Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium, Russia. Asia-Pacific: China, Japan, South Korea, India, Australia, Indonesia, Malaysia, Philippines, Singapore, Thailand South America: Brazil, Argentina, Colombia. Middle East and Africa (MEA): Saudi Arabia, United Arab Emirates, Egypt, Nigeria, South Africa, Rest of MEA Report Framework and Chapter Summary Chapter 1: Report Scope and Market Definition This chapter outlines the statistical boundaries and scope of the report. It defines the segmentation standards used throughout the study, including criteria for dividing the market by region, product type, application, and other relevant dimensions. It establishes the foundational definitions and classifications that guide the rest of the analysis. Chapter 2: Executive Summary This chapter presents a concise summary of the market’s current status and future outlook across different segments—by geography, product type, and application. It includes key metrics such as market size, growth trends, and development potential for each segment. The chapter offers a high-level overview of the Whole Genome and Exome Sequencing Market, highlighting its evolution over the short, medium, and long term. Chapter 3: Market Dynamics and Policy Environment This chapter explores the latest developments in the market, identifying key growth drivers, restraints, challenges, and risks faced by industry participants. It also includes an analysis of the policy and regulatory landscape affecting the market, providing insight into how external factors may shape future performance. Chapter 4: Competitive Landscape This chapter provides a detailed assessment of the market's competitive environment. It covers market share, production capacity, output, pricing trends, and strategic developments such as mergers, acquisitions, and expansion plans of leading players. This analysis offers a comprehensive view of the positioning and performance of top competitors. Chapters 5–10: Regional Market Analysis These chapters offer in-depth, quantitative evaluations of market size and growth potential across major regions and countries. Each chapter assesses regional consumption patterns, market dynamics, development prospects, and available capacity. The analysis helps readers understand geographical differences and opportunities in global markets. Chapter 11: Market Segmentation by Product Type This chapter examines the market based on product type, analyzing the size, growth trends, and potential of each segment. It helps stakeholders identify underexplored or high-potential product categories—often referred to as “blue ocean” opportunities. Chapter 12: Market Segmentation by Application This chapter analyzes the market based on application fields, providing insights into the scale and future development of each application segment. It supports readers in identifying high-growth areas across downstream markets. Chapter 13: Company Profiles This chapter presents comprehensive profiles of leading companies operating in the market. For each company, it details sales revenue, volume, pricing, gross profit margin, market share, product offerings, and recent strategic developments. This section offers valuable insight into corporate performance and strategy. Chapter 14: Industry Chain and Value Chain Analysis This chapter explores the full industry chain, from upstream raw material suppliers to downstream application sectors. It includes a value chain analysis that highlights the interconnections and dependencies across various parts of the ecosystem. Chapter 15: Key Findings and Conclusions The final chapter summarizes the main takeaways from the report, presenting the core conclusions, strategic recommendations, and implications for stakeholders. It encapsulates the insights drawn from all previous chapters. Table of Contents 1 Introduction to Research & Analysis Reports 1.1 Whole Genome and Exome Sequencing Market Definition 1.2 Whole Genome and Exome Sequencing Market Segments 1.2.1 Segment by Type 1.2.2 Segment by Application 2 Executive Summary 2.1 Global Whole Genome and Exome Sequencing Market Size 2.2 Market Segmentation – by Type 2.3 Market Segmentation – by Application 2.4 Market Segmentation – by Geography 3 Key Market Trends, Opportunity, Drivers and Restraints 3.1 Key Takeway 3.2 Market Opportunities & Trends 3.3 Market Drivers 3.4 Market Restraints 3.5 Market Major Factor Assessment 4 Global Whole Genome and Exome Sequencing Market Competitive Landscape 4.1 Global Whole Genome and Exome Sequencing Sales by Manufacturers (2020-2025) 4.2 Global Whole Genome and Exome Sequencing Revenue Market Share by Manufacturers (2020-2025) 4.3 Whole Genome and Exome Sequencing Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 4.4 New Entrant and Capacity Expansion Plans 4.5 Mergers & Acquisitions 5 Global Whole Genome and Exome Sequencing Market by Region 5.1 Global Whole Genome and Exome Sequencing Market Size by Region 5.1.1 Global Whole Genome and Exome Sequencing Market Size by Region 5.1.2 Global Whole Genome and Exome Sequencing Market Size Market Share by Region 5.2 Global Whole Genome and Exome Sequencing Sales by Region 5.2.1 Global Whole Genome and Exome Sequencing Sales by Region 5.2.2 Global Whole Genome and Exome Sequencing Sales Market Share by Region 6 North America Market Overview 6.1 North America Whole Genome and Exome Sequencing Market Size by Country 6.1.1 USA Market Overview 6.1.2 Canada Market Overview 6.1.3 Mexico Market Overview 6.2 North America Whole Genome and Exome Sequencing Market Size by Type 6.3 North America Whole Genome and Exome Sequencing Market Size by Application 6.4 Top Players in North America Whole Genome and Exome Sequencing Market 7 Europe Market Overview 7.1 Europe Whole Genome and Exome Sequencing Market Size by Country 7.1.1 Germany Market Overview 7.1.2 France Market Overview 7.1.3 U.K. Market Overview 7.1.4 Italy Market Overview 7.1.5 Spain Market Overview 7.1.6 Sweden Market Overview 7.1.7 Denmark Market Overview 7.1.8 Netherlands Market Overview 7.1.9 Switzerland Market Overview 7.1.10 Belgium Market Overview 7.1.11 Russia Market Overview 7.2 Europe Whole Genome and Exome Sequencing Market Size by Type 7.3 Europe Whole Genome and Exome Sequencing Market Size by Application 7.4 Top Players in Europe Whole Genome and Exome Sequencing Market 8 Asia-Pacific Market Overview 8.1 Asia-Pacific Whole Genome and Exome Sequencing Market Size by Country 8.1.1 China Market Overview 8.1.2 Japan Market Overview 8.1.3 South Korea Market Overview 8.1.4 India Market Overview 8.1.5 Australia Market Overview 8.1.6 Indonesia Market Overview 8.1.7 Malaysia Market Overview 8.1.8 Philippines Market Overview 8.1.9 Singapore Market Overview 8.1.10 Thailand Market Overview 8.1.11 Rest of APAC Market Overview 8.2 Asia-Pacific Whole Genome and Exome Sequencing Market Size by Type 8.3 Asia-Pacific Whole Genome and Exome Sequencing Market Size by Application 8.4 Top Players in Asia-Pacific Whole Genome and Exome Sequencing Market 9 South America Market Overview 9.1 South America Whole Genome and Exome Sequencing Market Size by Country 9.1.1 Brazil Market Overview 9.1.2 Argentina Market Overview 9.1.3 Columbia Market Overview 9.2 South America Whole Genome and Exome Sequencing Market Size by Type 9.3 South America Whole Genome and Exome Sequencing Market Size by Application 9.4 Top Players in South America Whole Genome and Exome Sequencing Market 10 Middle East and Africa Market Overview 10.1 Middle East and Africa Whole Genome and Exome Sequencing Market Size by Country 10.1.1 Saudi Arabia Market Overview 10.1.2 UAE Market Overview 10.1.3 Egypt Market Overview 10.1.4 Nigeria Market Overview 10.1.5 South Africa Market Overview 10.2 Middle East and Africa Whole Genome and Exome Sequencing Market Size by Type 10.3 Middle East and Africa Whole Genome and Exome Sequencing Market Size by Application 10.4 Top Players in Middle East and Africa Whole Genome and Exome Sequencing Market 11 Whole Genome and Exome Sequencing Market Segmentation by Type 11.1 Evaluation Matrix of Segment Market Development Potential (Type) 11.2 Global Whole Genome and Exome Sequencing Sales Market Share by Type (2020-2033) 11.3 Global Whole Genome and Exome Sequencing Market Size Market Share by Type (2020-2033) 11.4 Global Whole Genome and Exome Sequencing Price by Type (2020-2033) 12 Whole Genome and Exome Sequencing Market Segmentation by Application 12.1 Evaluation Matrix of Segment Market Development Potential (Application) 12.2 Global Whole Genome and Exome Sequencing Market Sales by Application (2020-2033) 12.3 Global Whole Genome and Exome Sequencing Market Size (M USD) by Application (2020-2033) 12.4 Global Whole Genome and Exome Sequencing Sales Growth Rate by Application (2020-2033) 13 Company Profiles 13.1 Eurofins Scientific SE 13.1.1 Eurofins Scientific SE Company Overview 13.1.2 Eurofins Scientific SE Business Overview 13.1.3 Eurofins Scientific SE Whole Genome and Exome Sequencing Major Product Offerings 13.1.4 Eurofins Scientific SE Whole Genome and Exome Sequencing Sales and Revenue fromWhole Genome and Exome Sequencing (2020-2025) 13.1.5 Key News 13.2 Agilent Technologies 13.2.1 Agilent Technologies Company Overview 13.2.2 Agilent Technologies Business Overview 13.2.3 Agilent Technologies Whole Genome and Exome Sequencing Major Product Offerings 13.2.4 Agilent Technologies Whole Genome and Exome Sequencing Sales and Revenue fromWhole Genome and Exome Sequencing (2020-2025) 13.2.5 Key News 13.3 Inc 13.3.1 Inc Company Overview 13.3.2 Inc Business Overview 13.3.3 Inc Whole Genome and Exome Sequencing Major Product Offerings 13.3.4 Inc Whole Genome and Exome Sequencing Sales and Revenue fromWhole Genome and Exome Sequencing (2020-2025) 13.3.5 Key News 13.4 Beijing Genomics Institute (BGI) 13.4.1 Beijing Genomics Institute (BGI) Company Overview 13.4.2 Beijing Genomics Institute (BGI) Business Overview 13.4.3 Beijing Genomics Institute (BGI) Whole Genome and Exome Sequencing Major Product Offerings 13.4.4 Beijing Genomics Institute (BGI) Whole Genome and Exome Sequencing Sales and Revenue fromWhole Genome and Exome Sequencing (2020-2025) 13.4.5 Key News 13.5 Hoffmann-La Roche Ltd 13.5.1 Hoffmann-La Roche Ltd Company Overview 13.5.2 Hoffmann-La Roche Ltd Business Overview 13.5.3 Hoffmann-La Roche Ltd Whole Genome and Exome Sequencing Major Product Offerings 13.5.4 Hoffmann-La Roche Ltd Whole Genome and Exome Sequencing Sales and Revenue fromWhole Genome and Exome Sequencing (2020-2025) 13.5.5 Key News 13.6 Bio-Rad Laboratories 13.6.1 Bio-Rad Laboratories Company Overview 13.6.2 Bio-Rad Laboratories Business Overview 13.6.3 Bio-Rad Laboratories Whole Genome and Exome Sequencing Major Product Offerings 13.6.4 Bio-Rad Laboratories Whole Genome and Exome Sequencing Sales and Revenue fromWhole Genome and Exome Sequencing (2020-2025) 13.6.5 Key News 13.7 Inc 13.7.1 Inc Company Overview 13.7.2 Inc Business Overview 13.7.3 Inc Whole Genome and Exome Sequencing Major Product Offerings 13.7.4 Inc Whole Genome and Exome Sequencing Sales and Revenue fromWhole Genome and Exome Sequencing (2020-2025) 13.7.5 Key News 13.8 GENEWIZ 13.8.1 GENEWIZ Company Overview 13.8.2 GENEWIZ Business Overview 13.8.3 GENEWIZ Whole Genome and Exome Sequencing Major Product Offerings 13.8.4 GENEWIZ Whole Genome and Exome Sequencing Sales and Revenue fromWhole Genome and Exome Sequencing (2020-2025) 13.8.5 Key News 13.9 Inc 13.9.1 Inc Company Overview 13.9.2 Inc Business Overview 13.9.3 Inc Whole Genome and Exome Sequencing Major Product Offerings 13.9.4 Inc Whole Genome and Exome Sequencing Sales and Revenue fromWhole Genome and Exome Sequencing (2020-2025) 13.9.5 Key News 13.10 Illumina 13.10.1 Illumina Company Overview 13.10.2 Illumina Business Overview 13.10.3 Illumina Whole Genome and Exome Sequencing Major Product Offerings 13.10.4 Illumina Whole Genome and Exome Sequencing Sales and Revenue fromWhole Genome and Exome Sequencing (2020-2025) 13.10.5 Key News 13.11 Inc 13.11.1 Inc Company Overview 13.11.2 Inc Business Overview 13.11.3 Inc Whole Genome and Exome Sequencing Major Product Offerings 13.11.4 Inc Whole Genome and Exome Sequencing Sales and Revenue fromWhole Genome and Exome Sequencing (2020-2025) 13.11.5 Key News 13.12 Laboratory Corporation of America Holdings 13.12.1 Laboratory Corporation of America Holdings Company Overview 13.12.2 Laboratory Corporation of America Holdings Business Overview 13.12.3 Laboratory Corporation of America Holdings Whole Genome and Exome Sequencing Major Product Offerings 13.12.4 Laboratory Corporation of America Holdings Whole Genome and Exome Sequencing Sales and Revenue fromWhole Genome and Exome Sequencing (2020-2025) 13.12.5 Key News 13.13 Novogene Corporation 13.13.1 Novogene Corporation Company Overview 13.13.2 Novogene Corporation Business Overview 13.13.3 Novogene Corporation Whole Genome and Exome Sequencing Major Product Offerings 13.13.4 Novogene Corporation Whole Genome and Exome Sequencing Sales and Revenue fromWhole Genome and Exome Sequencing (2020-2025) 13.13.5 Key News 13.14 Oxford Nanopore Technologies 13.14.1 Oxford Nanopore Technologies Company Overview 13.14.2 Oxford Nanopore Technologies Business Overview 13.14.3 Oxford Nanopore Technologies Whole Genome and Exome Sequencing Major Product Offerings 13.14.4 Oxford Nanopore Technologies Whole Genome and Exome Sequencing Sales and Revenue fromWhole Genome and Exome Sequencing (2020-2025) 13.14.5 Key News 13.15 Inc 13.15.1 Inc Company Overview 13.15.2 Inc Business Overview 13.15.3 Inc Whole Genome and Exome Sequencing Major Product Offerings 13.15.4 Inc Whole Genome and Exome Sequencing Sales and Revenue fromWhole Genome and Exome Sequencing (2020-2025) 13.15.5 Key News 13.16 Pacific Biosciences of California 13.16.1 Pacific Biosciences of California Company Overview 13.16.2 Pacific Biosciences of California Business Overview 13.16.3 Pacific Biosciences of California Whole Genome and Exome Sequencing Major Product Offerings 13.16.4 Pacific Biosciences of California Whole Genome and Exome Sequencing Sales and Revenue fromWhole Genome and Exome Sequencing (2020-2025) 13.16.5 Key News 13.17 Inc 13.17.1 Inc Company Overview 13.17.2 Inc Business Overview 13.17.3 Inc Whole Genome and Exome Sequencing Major Product Offerings 13.17.4 Inc Whole Genome and Exome Sequencing Sales and Revenue fromWhole Genome and Exome Sequencing (2020-2025) 13.17.5 Key News 13.18 QIAGEN N.V 13.18.1 QIAGEN N.V Company Overview 13.18.2 QIAGEN N.V Business Overview 13.18.3 QIAGEN N.V Whole Genome and Exome Sequencing Major Product Offerings 13.18.4 QIAGEN N.V Whole Genome and Exome Sequencing Sales and Revenue fromWhole Genome and Exome Sequencing (2020-2025) 13.18.5 Key News 13.19 Thermo Fisher Scientific Inc 13.19.1 Thermo Fisher Scientific Inc Company Overview 13.19.2 Thermo Fisher Scientific Inc Business Overview 13.19.3 Thermo Fisher Scientific Inc Whole Genome and Exome Sequencing Major Product Offerings 13.19.4 Thermo Fisher Scientific Inc Whole Genome and Exome Sequencing Sales and Revenue fromWhole Genome and Exome Sequencing (2020-2025) 13.19.5 Key News 13.20 Cytiva 13.20.1 Cytiva Company Overview 13.20.2 Cytiva Business Overview 13.20.3 Cytiva Whole Genome and Exome Sequencing Major Product Offerings 13.20.4 Cytiva Whole Genome and Exome Sequencing Sales and Revenue fromWhole Genome and Exome Sequencing (2020-2025) 13.20.5 Key News 13.20.6 Key News 14 Key Market Trends, Opportunity, Drivers and Restraints 14.1 Key Takeway 14.2 Market Opportunities & Trends 14.3 Market Drivers 14.4 Market Restraints 14.5 Market Major Factor Assessment 14.6 Porter's Five Forces Analysis of Whole Genome and Exome Sequencing Market 14.7 PEST Analysis of Whole Genome and Exome Sequencing Market 15 Analysis of the Whole Genome and Exome Sequencing Industry Chain 15.1 Overview of the Industry Chain 15.2 Upstream Segment Analysis 15.3 Midstream Segment Analysis 15.3.1 Manufacturing, Processing or Conversion Process Analysis 15.3.2 Key Technology Analysis 15.4 Downstream Segment Analysis 15.4.1 Downstream Customer List and Contact Details 15.4.2 Customer Concerns or Preference Analysis 16 Conclusion 17 Appendix 17.1 Methodology 17.2 Research Process and Data Source 17.3 Disclaimer 17.4 Note 17.5 Examples of Clients 17.6 DisclaimerResearch Methodology The research methodology employed in this study follows a structured, four-stage process designed to ensure the accuracy, consistency, and relevance of all data and insights presented. The process begins with Information Procurement, wherein data is collected from a wide range of primary and secondary sources. This is followed by Information Analysis, during which the collected data is systematically mapped, discrepancies across sources are examined, and consistency is established through cross-validation.
Subsequently, the Market Formulation phase involves placing verified data points into an appropriate market context to generate meaningful conclusions. This step integrates analyst interpretation and expert heuristics to refine findings and ensure applicability. Finally, all conclusions undergo a rigorous Validation and Publishing process, where each data point is re-evaluated before inclusion in the final deliverable. The methodology emphasizes bidirectional flow and reversibility between key stages to maintain flexibility and reinforce the integrity of the analysis.
Research Process The market research process follows a structured and iterative methodology designed to ensure accuracy, depth, and reliability. It begins with scope definition and research design, where the research objectives are clearly outlined based on client requirements, emerging market trends, and initial exploratory insights. This phase provides strategic direction for all subsequent stages of the research. Data collection is then conducted through both secondary and primary research. Secondary research involves analyzing publicly available and paid sources such as company filings, industry journals, and government databases to build foundational knowledge. This is followed by primary research, which includes direct interviews and surveys with key industry stakeholders—such as manufacturers, distributors, and end users—to gather firsthand insights and address data gaps identified earlier. Techniques included CATI (Computer-Assisted Telephonic Interviewing), CAWI (Computer-Assisted Web Interviewing), CAVI (Computer-Assisted Video Interviewing via platforms like Zoom and WebEx), and CASI (Computer-Assisted Self Interviewing via email or LinkedIn).
